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ABSTRACT
Passage through the Retinoblastoma protein (RB1)-
dependent restriction point and the loading of
minichromosome maintenance proteins (MCMs) are
two crucial events in G1-phase that help main-
tain genome integrity. Deregulation of these pro-
cesses can cause uncontrolled proliferation and can-
cer development. Both events have been extensively
characterized individually, but their relative timing
and inter-dependence remain less clear. Here, we
describe a novel method to simultaneously mea-
sure MCM loading and passage through the restric-
tion point. We exploit that the RB1 protein is an-
chored in G1-phase but is released when hyper-
phosphorylated at the restriction point. After extract-
ing cells with salt and detergent before fixation we
can simultaneously measure, by flow cytometry, the
loading of MCMs onto chromatin and RB1 binding to
determine the order of the two events in individual
cells. We have used this method to examine the rela-
tive timing of the two events in human cells. Whereas
in BJ fibroblasts released from G0-phase MCM load-
ing started mainly after the restriction point, in a
significant fraction of exponentially growing BJ and
U2OS osteosarcoma cells MCMs were loaded in G1-
phase with RB1 anchored, demonstrating that MCM
loading can also start before the restriction point.
These results were supported by measurements in
synchronized U2OS cells.
INTRODUCTION
Cancer cells are often deficient in the control of G1-phase
and therefore knowledge about the major regulatory events
in G1-phase is important for our understanding of car-
cinogenesis. Two events in G1 are the formation of the
pre-replicative complex (pre-RC) and passage through the
Retinoblastoma protein (RB1)-dependent restriction point.
RB1 was the first tumor suppressor discovered (1) and ab-
normal levels of pre-RC components can cause DNA dam-
age and genomic instability (reviewed in 2).
Formation of the pre-RC, culminating in the loading of
the six minichromosome maintenance (MCM) proteins, is
one of the first steps in preparation for DNA replication.
Pre-RCs form in G1-phase through a multistep process
called licensing: CDC6 is recruited to the origin recognition
complex (ORC) after exit from mitosis (3,4). Subsequently,
CDT1 and MCM2–7, the replicative DNA helicase, form
a complex and are recruited by CDC6 to the ORC to form
the pre-RC (5,6). Adenosine triphosphate bound to CDC6
and ORC undergoes hydrolysis, leading to the release of
CDT1 and CDC6 and to the loading of MCM2–7 helicases
onto DNA (6–8). A chain of events including phosphory-
lation by CDC7, recruitment of CDC45, further phospho-
rylations by cyclin-dependent kinases (CDKs) and recruit-
ment of several additional replication factors activate the
helicase and DNA replication is initiated (9,10). Once the
cells enter S-phase several of the licensing factors are de-
graded or inhibited, ensuring that no origin can be reli-
censed after replication has commenced (11–14). In this way
the formation and dissociation of the pre-RCs help ensur-
ing that the DNA is replicated once and only once per cell
cycle.
The restriction point was first described in 1974 as a spe-
cific time point in G1-phase when the cell becomes commit-
ted to another round in the cell cycle (15). Over the last four
decades the restriction point has been investigated exten-
sively, often focusing on the phosphorylation status of RB1
(1,16,17). RB1 is phosphorylated early in G1 by CDK4/6-
cyclinD (18,19). The common view was that increasing lev-
els of RB1-phosphorylation by CDK4/6-cyclin D through
G1 leads to a partial release of the E2F transcription factor
from its RB1-bound form, thereby enabling transcription
of E2F target genes, allowing passage through the restric-
tion point (reviewed in 20).However, recentwork has shown
that CDK4/6-cyclin D can only mono-phosphorylate RB1
and this phosphorylation activates rather than inactivates
RB1, stimulating its binding to E2F and thus inhibiting
transcription of E2F target genes (19,20). As G1-phase pro-
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gresses, the CDK2–cyclinE complex inactivates RB1 by fur-
ther phosphorylating the protein and this phosphorylation
is considered a molecular marker for the restriction point
(21). In this hyper-phosphorylated state, past the restriction
point, RB1 can no longer bind E2F. Free E2F can translo-
cate into the nucleus and stimulate transcription of target
genes (22), several of which are involved in DNA replica-
tion initiation. Notably, many pre-RC components, such
as MCM2–7, CDT1 and CDC6 have E2F binding sites in
their promoter (23–25), leading to the idea that RB1 hyper-
phosphorylation is likely to precede the loading of MCMs.
However, even though both the restriction point andMCM
loading have been extensively studied separately, the relative
timing of these processes and their inter-dependence remain
less clear.
Here we have developed a novel method that enables us
to simultaneously study MCM loading and RB1 hyper-
phosphorylation in single cells. By this method we can as-
sess the relative timing of the two events and thereby ad-
dress whether or not these events are connected and, if so,
in which order they appear. The results show that while
MCMs are often loaded after RB1 hyper-phosphorylation,
they can in many cases be loaded prior to RB1 hyper-
phosphorylation.
MATERIALS AND METHODS
Cell culture and synchronization
Human BJ fibroblast and human U2OS osteosarcoma cells
were cultivated in Dulbecco’s modified Eagle’s Medium
(DMEM) (Invitrogen) supplemented with 10% fetal bovine
serum and 1% Penicillin/Streptomycin at 37◦C in a humid-
ified environment with 5% CO2. Arrest of BJ cells in G0-
phase was achieved by growing the cells to 100% confluence
followed by addition of fresh culture medium and subse-
quent incubation for three additional days. For release of
cells from G0-phase, the cells were subcultured at low den-
sity. For synchronization with Nocodazole (Sigma-Aldrich)
the drug was present at 0.04 g/ml for 12 h before mitotic
cells were collected by manual shaking and washed three
times in phosphate buffered saline (PBS) and incubated in
regular medium. Irradiation was performed using an X-ray
generator (Faxitron CP160, 160kV, 6,3mA, 1Gy/min).
Extraction and fixation
To extract unattached proteins for flow cytometry analy-
sis, the medium was removed and cells were washed once
with PBS, followed by a quick rinse in 1 ml trypsin and
incubation for 2 min at 37◦C to detach the cells. The cells
were resuspended in DMEM and collected by centrifuga-
tion, and the cell pellet was treated with 750 l low salt ex-
traction buffer (0.1% Igepal CA-630, 10 mM NaCl, 5 mM
MgCl2, 0.1 mMPMSF, 10mMPotassium phosphate buffer
(pH 7.4)) for 5 min on ice. Then the cells were fixed by
adding 250 l of extraction buffer containing 10% formalin
(HT501128 SIGMA) (final concentration 2.5%) and incu-
bation was continued for 1 h on ice. The cells were washed
with PBS and stored at 4◦C for up to 24 h before staining
with antibodies. Unextracted cells were fixed in 2.5% forma-
lin for 1 h on ice before washing with PBS and permeabiliza-
tion in 1 ml 70% ethanol at −20◦C. To extract unattached
proteins for immunoblotting, cells were incubated 5 min on
ice with 1 ml low salt extraction buffer prior to cell lysis.
Immunoblots
Whole-cell lysates were prepared in 2× Laemmli sam-
ple buffer. Proteins were separated by Sodium dodecyl
sulphate-polyacrylamide gel electrophoresis, on 7% gels
(26). The proteins were transferred to a PVDF membrane
in a wet transfer cell (Bio-Rad) using a buffer containing
25 mM Trizma base and 192 mM Glycine. After transfer
the proteins were fixed to the membrane in 100% methanol
for 5 min. The membranes were blocked in 5% non-fat
milk before probing with the relevant antibody:  -tubulin,
diluted 1:10 000 (Sigma-Aldrich T6557), RB1 1:500 (BD
Biosciences 554136), RB1-phospho (ser795) 1:1000 (Ab-
cam ab47474). Detection was performed using an enhanced
chemiluminescence kit (Amersham Biosciences) and quan-
tified in a Chemi Genius (Syngene) with the software Gene-
Tools.
Flow cytometry
After fixation the samples were incubated with primary an-
tibodies (RB1 1:50 (BD Biosciences 554136, MCM3 1:100
(N-19, sc-9850)) and secondary antibodies (AlexaFlour 488
and 647) diluted 1:1000 in flow buffer (0.1% Igepal CA-
630, 6.5 mM Na2HPO4, 1.5 mM KH2PO4, 2.7 mM KCl,
137 mM NaCl, 0.5 mM ethylenediaminetetraacetic acid
(pH7.5)), containing 4% non-fat milk and stained with the
DNA-stain Hoechst 33258 (1.5 g/ml). A barcoding flow
cytometry technique was used to eliminate antibody stain-
ing variations between individual samples in the ionizing ir-
radiation experiment (Figure 3 and Supplementary Figure
S2). Four fixed samples were stained with different concen-
trations (0.125, 0.031, 0.0062 and 0.00078 ng/l) of Pacific
Blue (Invitrogen) for 30 min in the dark at room tempera-
ture and subsequently mixed into one tube. The mixed cells
were then stained as above, except that the secondary an-
tibodies were anti-goat Alexa Fluor 488 (1:1000) and anti-
mouse Dylight 549 (1:500), and the DNA-stain was FxCy-
cle Far Red (Life Technology). The samples were analyzed
on an LSRII flow cytometer (BD Biosciences) using Diva
or FlowJo software. All experiments were performed three
times or more.
RESULTS
Simultaneous measurements ofMCM loading and RB1 bind-
ing
Tounderstand the relationship between pre-RC loading and
the restriction point we developed a method to measure
both MCM loading and RB1 hyper-phosphorylation in in-
dividual cells by flow cytometry. MCMs are in vast excess
over replication origins in the cell and, in each cell cycle,
only a fraction of them becomes part of pre-RCs and bound
to chromatin (27). In order to remove unbound MCMs
the cells were extracted before fixation (28) and to mea-
sure loading of the MCM complex we used an antibody to
MCM3 (see ‘Materials andMethods’ section). Unextracted
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Figure 1. Basic experimental approach. (A) Flow cytometric analysis of U2OS cells pre-extracted with salt and detergent before fixation (extracted) or
fixed without pre-extraction (unextracted). Cells were stained with antibodies againstMCM3 (MCM) andRB1 (RB1) and theDNA-stainHoechst (DNA).
Density scatter plots are shown for MCM staining versus DNA content (top) and RB1 staining versus DNA content (bottom). (B) and (C) (i) Gating for
single cells based on the area (FL2A) and the width (FL2W) of the signal for DNA staining. (ii) Gate defining G1-phase (left), regions defining MCM-
positive cells (middle) and cells with RB1 anchored (right). (iii) Scatter plot ofMCMversus RB1 for the gated G1 cell population with quadrants indicating
the MCM- and RB1-positive and negative cells defined as in B (left), A schematic explanation of quadrants (right). In (C) the samples were stained with
secondary antibodies only.
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Figure 2. Validation of the method in BJ cells released from G0-phase. (A) Immunoblot analysis of BJ cells released from G0-phase after synchronization
by contact inhibition. Cells were pre-extracted with salt and detergent (extracted) or left unextracted (unextracted) before cell lysis and processed for
immunoblotting with antibodies against total RB1 (RB1), phosphorylated RB1 on Ser795 (pRB1-Ser795) and  -tubulin. RB1-pp indicates a hyper-
phoshorylated form of RB1 detected by the RB1 antibody. Time points indicate hours after release from G0-phase. Note that the blot shown for pRB-
Ser795 was from a separate gel than the others, and the corresponding  -tubulin blot is shown in Supplementary Figure S1A. (B) BJ cells were synchronized
and released as in (A) and analyzed by flow cytometry as in Figure 1B, at the indicated times after release. Lines in the density scatter plots (top and middle
rows) indicate regions defining positive and negative cells for either MCM or RB1. Gates for G1-cells are indicated in the DNA histograms (bottom).
(C) Scatter plots of MCM versus RB1 for the gated G1 cell population with quadrants indicating the MCM- and RB1-positive and negative cells defined
as in (B). Numbers indicate the percentages of G1 cells in each quadrant. (D) Column charts showing the percentages of MCM-positive G1 cells in the
scatter plots shown in (C) (quadrants Q1 and Q2). Black bars (Q2) indicate cells with RB1 anchored (before restriction point) and gray bars (Q1) cells
with RB1 hyper-phosphorylated and no longer anchored (after restriction point). Note that cells start passing the restriction point from 9 hours (RB1-pp
in A and two RB1 populations in (C) from 9 h) and S-phase cells are visible from about 15 h (S-phase pattern of MCM in the 15 h MCM plot in (B)). See
Supplementary Figure S1B for EdU incorporation versus MCM loading from a similar experiment.
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U2OS cells showed high levels of MCMs in all cell-cycle
phases, whereas extraction reduced the MCM signal and
gave a distinct pattern of MCM-positive cells (Figure 1A,
top). The pattern of MCM-positive cells showed increas-
ing amounts of chromatin-bound MCMs in G1-phase, fol-
lowed by a decrease during S-phase. This pattern is in agree-
ment with the interpretation that pre-RCs form during G1-
phase and the MCMs are offloaded as the replication forks
meet during S-phase (29,30). We conclude that our extrac-
tion procedure removes the MCM proteins not bound to
chromatin, leaving for detection only the fraction of MCM
proteins bound in pre-RC complexes.
Previous studies have shown that hypo-phosphorylated
RB1 is anchored to the nucleus of G1-phase cells (31),
whereas hyper-phosphorylated RB1, occurring past the re-
striction point, is not bound (28). Thus, we reasoned that
when cells are pre-extracted with low salt buffer before fixa-
tion, as described above, only G1-phase cells prior to the
restriction point retain bound RB1. After the restriction
point, RB1 is hyper-phosphorylated, released from its an-
chor and is washed out during the extraction (28). The cells
analyzed for MCM binding were co-stained with an an-
tibody against RB1. Like we found for the MCMs, there
were high levels of RB1 in all cell-cycle phases in the un-
extracted samples (Figure 1A bottom). However, after ex-
traction only some of the G1-phase cells were RB1-positive,
most likely representing cells prior to the restriction point.
Cells in S-phase showed a clear drop in the RB1 signal com-
pared to the RB1-positive population in G1-phase (Fig-
ure 1A bottom), in agreement with S-phase cells contain-
ing hyper-phosphorylated and unbound RB1. Thus, flow
cytometry using low-salt extraction can be used to detect
the RB1 phosphorylation status in single cells under con-
ditions in which bound MCMs can be detected simultane-
ously.
We then defined appropriate regions and gates to quan-
tify the results. First, single cells were gated based on the
width (FL2W) and area (FL2A) of the signal from DNA
staining, to exclude multimers of cells (Figure 1B (i)). Next,
regions were set to identify the MCM- and RB1-positive
cells. MCM-positive cells were defined as those with an
MCM-specific signal exceeding that obtained from cells at
the S/G2 border, where MCM offloading is presumed to
be complete. It should be noted that MCM loading takes
place during a time window in G1. MCM-positive cells in-
clude all cells that have started to load, regardless of where
in this time window they are or how many of their repli-
cation origins have assembled pre-RCs. RB1-positive cells
were defined based on the difference between the positive
cells in G1-phase and the negative cells in S-phase (Fig-
ure 1B (ii)). These regions are located at the same place
as regions set based on the secondary antibody control
(Figure 1C (ii)). Finally, G1-phase cells were gated based
on the DNA histogram obtained from the Hoechst sig-
nal. To minimize the number of S-phase cells in the gated
G1-population, only cells appearing in the left side of the
G1 peak (Figure 1B (ii)) were included in the gate. These
gates and regions were then used to define the MCM/RB1
status of the G1-cells (Figure 1 (iii)). The G1-cells were
displayed in a two-parametric (MCM versus RB1) plot
and four quadrants were defined: MCM-positive and RB1-
negative (MCM+/RB1−) are in quadrant 1 (Q1), MCM-
positive and RB1-positive (MCM+/RB1+) in quadrant 2
(Q2), MCM-negative and RB1-positive (MCM−/RB1+)
in quadrant 3 (Q3) and MCM-negative and RB1-negative
(MCM−/RB1−) in quadrant 4 (Q4). Thus, the cells in
Q2 and Q3 are before the restriction point, with hypo-
phosphorylated, anchored RB1 and with MCMs loaded
(Q2) or not loaded (Q3). The cells in Q1 are after the re-
striction point with hyper-phosphorylated RB1 and loaded
MCMs. However, the cells in Q4 may either be after the
restriction point with hyper-phosphorylated RB1 and the
MCMs not yet loaded, or before the restriction point very
early in G1 with RB1 not yet hypo-phosphorylated and the
MCMs not loaded.
Validation of the method: BJ cells released from stationary
phase
We used the above experimental setup to investigate the
loading of MCMs and the RB1 phosphorylation status in
normal fibroblasts (BJ) released from G0-phase. BJ cells
were synchronized in G0-phase by contact inhibition, re-
leased and analyzed by flow cytometry at different time
points until they entered S-phase. The RB1 phosphoryla-
tion status was also assessed by immunoblotting, show-
ing that hyper-phosphorylated RB1 appeared about 9 h
after release from G0-phase (Figure 2A, left panel and
Supplementary Figure S1A). Consistent with only hypo-
phosphorylated RB1 being anchored in the cell, the hyper-
phosphorylated form of RB1 was not detected in extracted
samples (Figure 2A, right panel). Furthermore, flow cyto-
metric analysis of extracted cells showed a distinct popula-
tion, with low RB1 signal, increasing from about 9 h (Fig-
ure 2B and C), correlating with the appearance of hyper-
phosphorylated RB1 from the same timepoint, as measured
by immunoblotting (Figure 2A). The population containing
not-anchored Rb in the early time points and in G0 is most
likely cells with RB1 not yet phosphorylated and therefore
not yet bound (18–20). We conclude that our flow cytomet-
ric analysis of anchored RB1 can be used as a measurement
of RB1 phosphorylation status. Therefore, the cells start
passing the restriction point about 9 h after release from
G0.
MCM loading increased from about 11 h (Figure 2C
and D and Supplementary Figure S1B). The increase in
the MCM-positive population from around 11 h occurred
mainly in Q1 (post-restriction point), while the number of
cells in Q2 (pre-restriction point) remained low and fairly
constant throughout the experiment (Figure 2D). Since the
MCM loading increased exclusively in the Q1 population,
the vast majority of BJ cells released fromG0-phase appear
to load MCMs after the restriction point.
Next, we wanted to check whether our method could de-
tect changes in the kinetics of RB1 phosphorylation and
MCM loading after induction of a radiation-induced G1
checkpoint arrest.We treated the BJ cells with ionizing radi-
ation 1 h after release fromG0-phase and analyzed the sam-
ples by immunoblotting and flow cytometry as above. In
addition, we employed bar-coding with Pacific Blue (32,33)
to eliminate any sample-to-sample variation in the defini-
tion of regions for MCM- and RB1-positive cells (Supple-
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Figure 3. RB1 hyper-phosphorylation and MCM loading after ionizing radiation. (A) Immunoblot analysis of BJ cells synchronized and released as in
Figure 2A and either treated (+) or not treated (−) with 6 Gy X-ray irradiation at 1 h after release. Cells were processed for immunoblotting similar to
the unextracted samples in Figure 2A, with antibodies against total RB1 (RB1) and  -tubulin. (B) BJ cells were synchronized and treated as in (A) and
analyzed by flow cytometry as in Figure 2B, except that bar-coding with Pacific Blue was included to minimize sample-to-sample variation. Two non-
irradiated and two irradiated samples (e.g. 10 and 13 h) were bar-coded with different concentrations of Pacific Blue and mixed before antibody staining
and analysis, allowing the use of identicalMCMandRB1 regions for the four samples (Supplementary Figure S1A). The individual samples were thereafter
separated by gating on the Pacific Blue-specific signal (Supplementary Figure S1B). (C) Scatter plots of MCM versus RB1 for the gated G1 populations in
(B). (D) Column charts showing the percentages of MCM-positive cells in the scatter plots shown in (B), similar as in Figure 2D. Mean values from three
independent experiments are shown. Error bars represent standard error of the mean.
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mentary Figure S2). Since the unirradiated control cells
showed a gradual increase of hyper-phosphorylated RB1
from around 9 h (Figure 2A), we examined the irradiated
cells at 10–24 h after release. In agreement with a radiation-
induced G1-arrest, immunoblot analysis clearly demon-
strated a lack of RB1 hyper-phosphorylation in the irra-
diated samples at 10–24 h after release (Figure 3A). Con-
sistently, flow cytometric analysis of the irradiated, pre-
extracted samples lacked the cell population with low RB1
signal at all time points, meaning that all the irradiated cells
were arrested before the restriction point with bound RB1
(Figure 3B and C). In agreement with these findings, the ir-
radiated cells did not enter S-phase during the course of this
experiment, as seen by lack of increased DNA content (Fig-
ure 3B, bottom row). At all times, the MCM loading was
higher in the non-irradiated than in the irradiated cells (Fig-
ure 3D). This difference was due to the population of cells in
Q1 appearing selectively in the non-irradiated samples, rep-
resenting cells with loadedMCMs past the restriction point
(Figure 3D).We conclude that radiation caused an arrest of
the cells prior to the restriction point accompanied by a de-
lay in MCM loading. These results demonstrate that our
method can detect radiation-induced changes in RB1 phos-
phorylation andMCM loading and support the conclusion
above that MCM loading occurs after the restriction point
in BJ cells released from G0-phase.
Loading ofMCMs before the restriction point in cycling cells
We applied the same method to examine the relative tim-
ing of MCM loading and RB1 hyper-phosphorylation in
unperturbed, exponentially growing BJ and U2OS cells
(Figure 4A and B). On average about 14 and 11% of the
G1 population of BJ and U2OS cells, respectively, ap-
peared in Q2 (Figure 4C), representing cells that have hypo-
phosphorylated RB1 and loaded MCMs. The fraction of
cells in Q2 suggests that a sizeable proportion of the G1-
cells can load MCMs before RB1 is hyper-phosphorylated.
On the other hand, about 7% (BJ) and 55% (U2OS) of the
cells inG1-phase appeared inQ1 (after restriction point and
with loaded MCMs) and a proportion of these cells most
likely load MCMs after RB1 hyper-phosphorylation (Fig-
ure 4C). It is interesting to note that the fraction of cells
with MCM loaded after the restriction point (Q1) was very
different in the two cell lines. This difference likely reflects a
longer G1-phase in BJ cells compared to U2OS cells. When
G1 is longer, a higher fraction of the G1 cells are before
the restriction point, since the length of G1 after the re-
striction point does not vary much from cell line to cell
line (28). Furthermore, a fraction of exponentially growing
BJ cells appeared to have loaded MCMs already in G2/M-
phase (Figure 4A top left plot, MCM staining in cells with
G2/M-phase DNA content). Although we do not know
at what point in G2/M-phase these cells loaded MCMs,
these results may support previous reports where MCM
loading was shown to start in late mitosis (34,35). Alterna-
tively, some of these cells might be post-mitotic binuclear
G1 cells that have not completed cytokinesis. Interestingly,
the G2/M cells with loaded MCMs contained bound RB1
(Supplementary Figure S3), indicating MCM loading be-
fore RB1 hyper-phosphorylation. Altogether, these results
suggest that there is no strict order of MCM loading versus
RB1 hyper-phosphorylation in exponentially growing BJ or
U2OS cells.
U2OS cells released fromNocodazole block can loadMCMs
before RB1 hyper-phosphorylation
To further examine the order of RB1 hyper-
phosphorylation and MCM loading, U2OS cells were
treated with the mitotic inhibitor Nocodazole for 12 h, the
mitotic cells were collected and released into the cell cycle,
and the status of MCM and RB1 were analyzed as above.
Under these conditions the cells started entering S-phase
by 10 h after release, as judged by an increase in cellular
DNA content (Figure 5A, bottom row). The loading of
MCMs started very early in G1-phase and 4 h after release
about 40% of the cells had loaded MCMs (Figure 5A–C,
4 h time point, quadrants Q1 + Q2). Immunoblotting
showed the presence of hyper-phosphorylated RB1 at all
time points (Figure 5D, left panel), and therefore RB1 was
hyper-phosphorylated already very early in G1-phase in a
large proportion of the cells. However, a subpopulation of
cells with hypo-phosphorylated, anchored RB1 was also
present at all timepoints, as seen by both flow cytometric
analyses (Figure 5A–C, quadrants Q2 + Q3) and by im-
munoblotting of extracted samples (Figure 5D, right panel,
RB1 band). Analyses of MCM versus RB1 in G1-phase
cells revealed that the fraction of cells in Q2 increased
from 6–8 h after release (Figure 5B and C), meaning G1
cells with loaded MCMs and anchored RB1 before the
restriction point. At 8 h about 25% of the cells were in Q2
and this population increased to 38% by 12 h (Figure 5A
and B, 8 and 12 h timepoints). Thus, in a proportion of
the G1-cells, the MCMs were loaded prior to RB1 hyper-
phosphorylation, consistent with our conclusion above
that MCM loading can occur both before and after RB1
hyper-phosphorylation. Of note, the fraction of cells in Q2
started to increase at a later time (6–8 h) after mitosis than
the fraction of cells in Q1 (1.5–4 h). Thus, two different
waves of MCM loading appear to occur after release from
Nocodazole arrest. Interestingly, this finding is analogous
to those in a recent report suggesting the existence of
two populations in cells exiting from mitosis; one with
immediate high CDK activity rapidly entering S-phase and
the other with low CDK activity entering S-phase several
hours later (36).
DISCUSSION
We have developed a novel method allowing us to study the
order of MCM loading and RB1 hyper-phosphorylation in
single cells by flow cytometry. In this method we have ex-
ploited the fact that hyper-phosphorylation of RB1 at the
restriction point is accompanied by a loss of RB1 anchor-
ing in the cell (28). Passage through the restriction point
(i.e. RB1 anchoring status) and MCM loading can be si-
multaneously measured by antibody staining following a
common extraction procedure with salt and detergent. The
flow-cytometric analysis makes it possible to rapidly assess
MCM loading and the phosphorylation status of RB1 in
thousands of individual cells. Because we are looking at
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Figure 4. MCMs can be loaded before RB1 hyper-phosphorylation in exponentially growing cells. (A) Exponentially growing BJ or U2OS cells were
analyzed by flow cytometry for MCMs and RB1 as in Figure 1B. Lines in the density scatter plots (top and middle) indicate the regions defining positive
and negative cells for either MCM or RB1. Gates for G1-cells are indicated in the DNA histograms (bottom). (B) Scatter plots of MCM versus RB1 for
the gated G1 populations in (A). (C) Quantification of the percentages of G1 cells in each quadrant from scatter plots as in (B). Mean values from five
experiments are shown for BJ (black bars) and U2OS (gray bars) cells. Error bars represent standard error of mean.
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Figure 5. U2OS cells released from Nocodazole block can load MCMs before RB1 hyper-phosphorylation. (A) U2OS cells synchronized by release from
Nocodazole-arrest were analyzed by flow cytometry for MCMs and RB1 as in Figure 1B. The time points (2–12 h) indicate times after release from the
Nocodazole-arrest. Lines in the density scatter plots (top and middle) indicate the regions defining positive and negative cells for either MCM or RB1.
Gates for G1-cells are indicated in the DNA histograms (bottom). (B) Scatter plots of MCM versus RB1 for the gated G1 populations in (A). (C) Column
charts showing the percentages of MCM-positive cells (quadrants Q1 and Q2) in the scatter plots shown in (B). Mean values from three independent
experiments are shown. Error bars represent standard error of the mean. (D) Immunoblot analysis as in Figure 2A of unextracted and extracted U2OS
cells. Cells were synchronized and released as in (A). The time points indicate time after release from Nocodazole-arrest.
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both parameters simultaneously, this method can be used to
address how these two events are coordinated. The method
is fairly straightforward and can be utilized to study RB1
hyper-phosphorylation and the loading of MCMs under
different conditions and after different stresses, as well as
to investigate other proteins anchored in the cell.
Interestingly, our results suggest that a fraction of expo-
nentially growing U2OS and BJ cells and of U2OS cells re-
leased from Nocodazole load MCMs before the RB1 pro-
tein is hyper-phoshorylated and presumably before the E2F
transcription factors are activated (Figures 4 and 5). How-
ever, BJ cells released fromG0-phase did not appear to load
MCMs before RB1 hyper-phosphorylation (Figures 2 and
3). This difference between synchronized and exponentially
growing BJ cells is likely due to a delayed MCM loading
in the cells released from G0-phase as compared to expo-
nentially growing cells. Factors needed for MCM loading
may be more available in cycling cells, making it possible
to start MCM loading before RB1 hyper-phosphorylation.
However, two aspects of the regulation of CDC6 can in-
duce a delay in pre-RC loading when the cells are arrested in
G0. First, arrest in G0-phase strongly reduces CDC6 pro-
tein levels and CDC6 needs to be synthesized de novo as
cells return to G1-phase (37–39). Second, phosphorylation
of CDC6 by CDK2/Cyclin E precedes MCM loading in
cells released from G0-phase (40), further postponing pre-
RC loading.
Our results show that irradiation of BJ cells released from
G0-phase significantly delayedRB1 hyper-phosphorylation
as well as MCM loading (Figure 3). The observed inhi-
bition of RB1 hyper-phosphorylation after ionizing radia-
tion is consistent with previous studies (41). The delay in
loading of MCMs after irradiation may be due to degrada-
tion of CDT1 and CDC6 in irradiated human cells (42,43).
Whether the delayed hyper-phosphorylation of RB1 and
subsequent lack of E2F-mediated transcription of MCMs
also contributes to the delayedMCM loading after ionizing
radiation is not known and would be an interesting issue for
further investigations.
The classic model is that the restriction point coincides
with RB1 hyper-phosphorylation which, in turn, leads to
E2F activation and induction of transcripts required for
S-phase entry, including those required for MCM loading
(44). Our finding that MCM loading can occur before RB1
hyper-phosphorylation in a sizeable fraction of exponen-
tially growing cells is apparently in conflict with this model.
However, recent reports have indicated that the classic view
of the restriction point and regulation of G1/S by E2F
needs to be revisited (45–48) and, in particular, that E2F-
induced transcripts are not essential for entry into S-phase
(48). Furthermore, in vivo studies in E2F-knockout mice
have shown that E2F proteins are not essential for prolifer-
ation, although an increase in DNA damage and apoptosis
is observed during such proliferation, consistent with a role
in transcriptional control (16,49,50). Our result that MCM
loading can occur before RB1 hyper-phosphorylation im-
plies that the release of E2F from RB1 complexes and E2F-
driven transcription is not essential for pre-RC formation.
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